# National Surveillance and Prevention of Neonatal VAP

> **NCT07109791** · — · RECRUITING · sponsor: **University of Alberta** · enrollment: 1500 (estimated)

## Conditions studied

- Ventilator-Associated Pneumonia (VAP), Neonatal
- Bronchopulmonary Dysplasia (BPD)
- Antibiotic-Resistant Organisms (AROs)
- Health-Care Associated Infection (HAI)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07109791
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2029-06
- **Final completion:** 2029-09
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2026-02-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07109791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07109791, "National Surveillance and Prevention of Neonatal VAP". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07109791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*